249 related articles for article (PubMed ID: 18930405)
1. 3D-QSAR studies of heterocyclic quinones with inhibitory activity on vascular smooth muscle cell proliferation using pharmacophore-based alignment.
Ryu CK; Lee Y; Park SG; You HJ; Lee RY; Lee SY; Choi S
Bioorg Med Chem; 2008 Nov; 16(22):9772-9. PubMed ID: 18930405
[TBL] [Abstract][Full Text] [Related]
2. The development of 3D-QSAR study and recursive partitioning of heterocyclic quinone derivatives with antifungal activity.
Choi SY; Shin JH; Ryu CK; Nam KY; No KT; Park Choo HY
Bioorg Med Chem; 2006 Mar; 14(5):1608-17. PubMed ID: 16263301
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of 2-phenyl-1H-benzo[d]imidazole-4,7-diones as vascular smooth muscle cell proliferation inhibitors.
Ryu CK; Lee RY; Lee SY; Chung HJ; Lee SK; Chung KH
Bioorg Med Chem Lett; 2008 May; 18(9):2948-51. PubMed ID: 18400498
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of quinoxaline-5,8-diones that inhibit vascular smooth muscle cell proliferation.
Chung HJ; Jung OJ; Chae MJ; Hong SY; Chung KH; Lee SK; Ryu CK
Bioorg Med Chem Lett; 2005 Jul; 15(14):3380-4. PubMed ID: 15950466
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophore-based 3D-QSAR of HIF-1 inhibitors.
Chung JY; Pasha FA; Cho SJ; Won M; Lee JJ; Lee K
Arch Pharm Res; 2009 Mar; 32(3):317-23. PubMed ID: 19387572
[TBL] [Abstract][Full Text] [Related]
6. Pharmacophore and docking-based combined in-silico study of KDR inhibitors.
Pasha FA; Muddassar M; Neaz MM; Cho SJ
J Mol Graph Model; 2009 Aug; 28(1):54-61. PubMed ID: 19447057
[TBL] [Abstract][Full Text] [Related]
7. A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators.
Labrie P; Maddaford SP; Fortin S; Rakhit S; Kotra LP; Gaudreault RC
J Med Chem; 2006 Dec; 49(26):7646-60. PubMed ID: 17181148
[TBL] [Abstract][Full Text] [Related]
8. Consensus superiority of the pharmacophore-based alignment, over maximum common substructure (MCS): 3D-QSAR studies on carbamates as acetylcholinesterase inhibitors.
Chaudhaery SS; Roy KK; Saxena AK
J Chem Inf Model; 2009 Jun; 49(6):1590-601. PubMed ID: 19441865
[TBL] [Abstract][Full Text] [Related]
9. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.
Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN
Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional quantitative structure-activity relationship studies on novel series of benzotriazine based compounds acting as Src inhibitors using CoMFA and CoMSIA.
Gueto C; Ruiz JL; Torres JE; Méndez J; Vivas-Reyes R
Bioorg Med Chem; 2008 Mar; 16(5):2439-47. PubMed ID: 18065233
[TBL] [Abstract][Full Text] [Related]
11. 3D-QSAR CoMFA/CoMSIA studies on 5-aryl-2,2-dialkyl-4-phenyl-3(2H)-furanone derivatives, as selective COX-2 inhibitors.
Puntambekar DS; Giridhar R; Yadav MR
Acta Pharm; 2006 Jun; 56(2):157-74. PubMed ID: 16613723
[TBL] [Abstract][Full Text] [Related]
12. Comparative molecular field analysis and comparative molecular similarity indices analysis of thalidomide analogues as angiogenesis inhibitors.
Lepper ER; Ng SS; Gütschow M; Weiss M; Hauschildt S; Hecker TK; Luzzio FA; Eger K; Figg WD
J Med Chem; 2004 Apr; 47(9):2219-27. PubMed ID: 15084120
[TBL] [Abstract][Full Text] [Related]
13. Understanding the antitumor activity of novel tricyclicpiperazinyl derivatives as farnesyltransferase inhibitors using CoMFA and CoMSIA.
Puntambekar DS; Giridhar R; Yadav MR
Eur J Med Chem; 2006 Nov; 41(11):1279-92. PubMed ID: 16919851
[TBL] [Abstract][Full Text] [Related]
14. 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment.
Chen Y; Li H; Tang W; Zhu C; Jiang Y; Zou J; Yu Q; You Q
Eur J Med Chem; 2009 Jul; 44(7):2868-76. PubMed ID: 19136179
[TBL] [Abstract][Full Text] [Related]
15. Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA models.
Puntambekar DS; Giridhar R; Yadav MR
Eur J Med Chem; 2008 Jan; 43(1):142-54. PubMed ID: 17448576
[TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR studies of arylcarboxamides with inhibitory activity on InhA using pharmacophore-based alignment.
Lu XY; Chen YD; You QD
Chem Biol Drug Des; 2010 Feb; 75(2):195-203. PubMed ID: 20028393
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional quantitative structure activity relationship (3D-QSAR) analysis for in vitro toxicity of chlorophenols to HepG2 cells.
Liu Y; Chen JN; Zhao JS; Yu HX; Wang XD; Jiang J; Jin HJ; Zhang JF; Wang LS
Chemosphere; 2005 Aug; 60(6):791-5. PubMed ID: 15946721
[TBL] [Abstract][Full Text] [Related]
18. Development of CoMFA and CoMSIA models of cytotoxicity data of anti-HIV-1-phenylamino-1H-imidazole derivatives.
Basu A; Jasu K; Jayaprakash V; Mishra N; Ojha P; Bhattacharya S
Eur J Med Chem; 2009 Jun; 44(6):2400-7. PubMed ID: 19000644
[TBL] [Abstract][Full Text] [Related]
19. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA.
Yi P; Fang X; Qiu M
Eur J Med Chem; 2008 May; 43(5):925-38. PubMed ID: 17698256
[TBL] [Abstract][Full Text] [Related]
20. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
